Faculty: Patricia J. Keely
Professor, Cell & Regenerative Biology
Director, Molecular and Cellular Pharmacology Program
|Contact:|| 227 Bock, Linden Drive |
|Training Areas:||Molecular & Cellular Pharmacology|
Cellular & Molecular Biology
Appropriate cellular interactions with the extracellular matrix (ECM) help to establish normal cellular architecture and differentiation. During oncogenic transformation, these normal interactions with the ECM are profoundly altered, resulting in cells that lose their polarization and differentiation, lose anchorage dependent growth control, and acquire a migratory, invasive phenotype. Our lab is interested in understanding, at a molecular level, how cellular interactions with the ECM determine differentiation and epithelial polarization, and how these interactions are altered during carcinogenesis to result in invasive, metastatic carcinoma.
Figure 1. Mammary epithelial cells cultured in 3D collagen gels differentiate into tubule structures. This differentiation is disrupted when cells are cultured in dense 3D collagen gels, providing a model system for understanding the molecular underpinnings for cellularresponses to matrix density
Understanding molecular mechanisms underlying breast cancer risk due to breast density
Patients with “dense” breast tissue have a four to six-fold increased risk of developing breast carcinomas. In fact, 1/3 of all breast cancer cases are attributed to breast density, making it one of the greatest risk factors for carcinoma. Increased breast density is associated with a significant increase in the deposition of connective tissue, or extracellular matrix (ECM) components, most notably the protein, collagen. We have been developing model systems to understand why increased breast density results in an increased risk for developing breast carcinoma. We find in a simple in vitro model that increasing the density of collagen in the matrix is sufficient to disrupt breast epithelial differentiation, suggesting that matrix density is itself an important regulator of cellular behavior. Additionally, we are employing a mouse strain engineered to have more collagen in its connective tissue. Mouse tumor studies are underway to directly test whether increased collagen density will enhance tumor formation or tumor metastasis.
Figure 2. Mouse mammary carcinoma cells (blue) invading into the surrounding collagen stroma (green/yellow) in fresh, unstained, unfixed tissue, and visualized by Fluorescent Lifetime Imaging Microscopy
State of the art imaging approaches are being used to characterize the collagen structure in normal glands and around tumors so that we can better understand the physical relationship between cells and the collagen fibers found in breast tissue. We find evidence for a collagen “signature” that is present in even before a tumor is palpable, predicting where a tumor will soon arise. We are investigating whether this signature can be developed as a tool to aid in diagnosing human breast carcinoma at an earlier stage.
Using biochemical and DNA microarray approaches, we are characterizing several biochemical and genetic changes that occur in cells that encounter dense matrices. Dense collagen environments activate signal pathways within cells that result in a more tumor-like behavior: increased cell proliferation or growth, decreased cell death, and increased ability to invade into nearby tissues. We expect that our studies to characterize the molecular response of cells to dense collagen matrices will allow us to better understand tumor progression.
Molecular signaling events related to cell interactions with the ECM
Cells interact with the ECM through a variety of cell surface receptors, the best understood of which are members of the integrin family. Much remains to be determined regarding the specific molecular players and signaling pathways downstream of integrins, and how these pathways are involved in the progression of various diseases. Therefore, part of the focus of the lab is to investigate signaling events through the integrin family of receptors. A second aspect of this work is to investigate how small GTPases of the Ras superfamily, some of which are known or suspected oncogenes, affect the response of cells to the ECM. Specifically, we have focused on R-Ras and Rho, which we find alter the way breast epithelial cells respond to the ECM, promoting cellular migration and invasion. We are particularly interested in studying signaling events using state of the art imaging approaches to understand how small GTPases function in a spatial and temporal manner during cell migration.
Honors & Awards
- 2013 - Romnes Faculty Fellowship
- 2001 - Shaw Scientist Award
- Susan G. Komen-AACR Career Development Award
- Howard Hughes Medical Institute Start-up Award
- NIH FIRST award
- NIH National Research Service Award Postdoctoral Fellowship
- Lucille P. Markey Postdoctoral Fellowship
- March of Dimes Postdoctoral and Predoctoral Fellowships
- Bacanar Research Award
Other Positions & Affiliations
- Not available
- Curran CS, Keely PJ. Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition. Matrix Biol. 2012 Dec 20. doi:pii: S0945-053X(12)00153-9. 10.1016/j.matbio.2012.11.016. [Epub ahead of print] PMID: 23262216
- Heck JN, Ponik SM, Garcia-Mendoza MG, Pehlke CA, Inman DR, Eliceiri KW, Keely PJ. Microtubules regulate GEF-H1 in response to extracellular matrix stiffness. Mol Biol Cell. 2012 Jul;23(13):2583-92. doi: 10.1091/mbc.E11-10-0876. Epub 2012 May 16. PMID: 22593214
- Conklin MW, Keely PJ. Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers. Cell Adh Migr. 2012 May-Jun;6(3):249-60. doi: 10.4161/cam.20567. Epub 2012 May 1. Review. PMID: 22568982
- Ajeti V, Nadiarnykh O, Ponik SM, Keely PJ, Eliceiri KW, Campagnola PJ (2011). Structural changes in mixed Col I/Col V collagen gels probed by SHG microscopy: implications for probing stromal alterations in human breast cancer. Biomed Opt Express. 2(8):2307-16. PMID: 21833367
- Keely PJ (2011). Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. J Mammary Gland Biol Neoplasia. 16(3):205-19. PMID: 21822945
- Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, Friedl A, Keely PJ (2011). Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol. 178(3):1221-32. PMID: 21356373
- Sung KE, Yang N, Pehlke C, Keely PJ, Eliceiri KW, Friedl A, Beebe DJ (2011).Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integr Biol (Camb). 3(4):439-50. PMID: 21135965
- Conklin MW, Ada-Nguema A, Parsons M, Riching KM, Keely PJ (2010). R-Ras regulates beta1-integrin trafficking via effects on membrane ruffling and endocytosis. BMC Cell Biol. 11:14. PMID: 20167113
- Provenzano PP, Keely PJ (2009). The role of focal adhesion kinase in tumor initiation and progression. Cell Adh Migr. 3(4):347-50. PMID: 19690467
- Sung KE, Su G, Pehlke C, Trier SM, Eliceiri KW, Keely PJ, Friedl A, Beebe DJ (2009). Control of 3-dimensional collagen matrix polymerization for reproducible human mammary fibroblast cell culture in microfluidic devices. Biomaterials. 30(27):4833-41. PMID: 19540580
- Gehler S, Baldassarre M, Lad Y, Leight JL, Wozniak MA, Riching KM, Eliceiri KW, Weaver VM, Calderwood DA, Keely PJ (2009). Filamin A-beta1 integrin complex tunes epithelial cell response to matrix tension. Mol Biol Cell. 20(14):3224-38. PMID: 19458194